Details for New Drug Application (NDA): 020468
✉ Email this page to a colleague
The generic ingredient in NASACORT ALLERGY 24 HOUR is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 020468
Tradename: | NASACORT ALLERGY 24 HOUR |
Applicant: | Chattem Sanofi |
Ingredient: | triamcinolone acetonide |
Patents: | 0 |
Pharmacology for NDA: 020468
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 020468
Suppliers and Packaging for NDA: 020468
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468 | NDA | Chattem, Inc. | 41167-5800 | 41167-5800-1 | 1 BOTTLE, SPRAY in 1 CARTON (41167-5800-1) / 30 SPRAY, METERED in 1 BOTTLE, SPRAY |
NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468 | NDA | Chattem, Inc. | 41167-5800 | 41167-5800-2 | 2 BOTTLE, SPRAY in 1 CARTON (41167-5800-2) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY |
Profile for product number 002
Active Rx/OTC/Discontinued: | OTC | Dosage: | SPRAY, METERED;NASAL | Strength | 0.055MG/SPRAY | ||||
Approval Date: | Oct 11, 2013 | TE: | RLD: | Yes |
Expired US Patents for NDA 020468
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | ⤷ Subscribe | ⤷ Subscribe |
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | ⤷ Subscribe | ⤷ Subscribe |
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription